Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' PABINGER I' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 94 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Pabinger-Fasching, I
      Is there a specific haemostasis in the elderly?

      INFUSION THERAPY AND TRANSFUSION MEDICINE-INFUSIONSTHERAPIE UND TRANSFUSIONSMEDIZIN
    2. Pabinger, I; Grafenhofer, H; Kaider, A; Ilic, A; Eichinger, S; Quehenberger, P; Husslein, P; Mannhalter, C; Lechner, K
      Preeclampsia and fetal loss in women with a history of venous thromboembolism

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    3. Partsch, H; Niessner, H; Bergau, L; Blattler, W; Cerny, J; Gerlach, H; Haas, P; Haas, S; Hirschl, M; Korninger, H; Kyrle, P; Landgraf, H; Mahler, F; Minar, E; Pabinger, I; Prinz, A; Rabe, E; Radner, A; Ramelet, AA; Schobersberger, W; Schuller-Petrovic, S; Stoberl, C; Zinnagl, N
      Traveller's thrombosis 2001

      PHLEBOLOGIE
    4. Rintelen, C; Pabinger, I; Bettelheim, P; Lechner, K; Kyrle, PA; Knobl, P; Schneider, B; Mannhalter, C
      Impact of the factor II: G20210A variant on the risk of venous thromboembolism in relatives from families with the factor V: R506Q mutation

      EUROPEAN JOURNAL OF HAEMATOLOGY
    5. Kuhle, S; Lane, DA; Jochmanns, K; Male, C; Quehenberger, P; Lechner, K; Pabinger, I
      Homozygous antithrombin deficiency type II (99 Leu to Phe mutation) and childhood thromboembolism

      THROMBOSIS AND HAEMOSTASIS
    6. Neunteufl, T; Heher, S; Stefenelli, T; Pabinger, I; Gisslinger, H
      Endothelial dysfunction in patients with polycythaemia vera

      BRITISH JOURNAL OF HAEMATOLOGY
    7. Jansen, M; Schmaldienst, S; Banyai, S; Quehenberger, P; Pabinger, I; Derfler, K; Horl, WH; Knobl, P
      Treatment of coagulation inhibitors with extracorporeal immunoadsorption (Ig-Therasorb)

      BRITISH JOURNAL OF HAEMATOLOGY
    8. Deguchi, H; Fernandez, JA; Pabinger, I; Heit, JA; Griffin, JH
      Plasma glucosylceramide deficiency as potential risk factor for venous thrombosis and modulator of anticoagulant protein C pathway

      BLOOD
    9. Lalouschek, W; Aull, S; Serles, W; Wolfsberger, M; Deecke, L; Pabinger-Fasching, I; Mannhalter, C
      The relation between erythrocyte volume and folate levels is influenced bya common mutation in the methylenetetrahydrofolate reductase (MTHFR) gene (C677T)

      JOURNAL OF INVESTIGATIVE MEDICINE
    10. Salzer-Muhar, U; Pabinger-Fasching, I; Zacherl-Wightman, S
      Is there a possible role for haemostasis in the development of perigraft reaction complicating the modified Blalock Taussig shunt

      CARDIOLOGY IN THE YOUNG
    11. Quehenberger, P; Handler, S; Mannhalter, C; Pabinger-Fasching, I; Speiser, W
      Evaluation of a highly specific functional test for the detection of factor V Leiden

      INTERNATIONAL JOURNAL OF CLINICAL & LABORATORY RESEARCH
    12. Stoiser, B; Knobl, P; Fonatsch, C; Haas, OA; Mitterbauer, G; Weltermann, A; Geissler, K; Valent, P; Sperr, W; Pabinger, I; Lechner, K; Jaeger, U
      Prognosis of patients with a second relapse of acute myeloid leukemia

      LEUKEMIA
    13. Gandrille, S; Borgel, D; Sala, N; Espinosa-Parrilla, Y; Simmonds, R; Rezende, S; Lind, B; Mannhalter, C; Pabinger, I; Reitsma, PH; Formstone, C; Cooper, DN; Saito, H; Suzuki, K; Bernardi, F; Aiach, M
      Protein S deficiency: A database of mutations - Summary of the first update

      THROMBOSIS AND HAEMOSTASIS
    14. Male, C; Lechner, K; Speiser, W; Pabinger, I
      Transient lupus anticoagulants in children: Stepwise disappearance of diagnostic features

      THROMBOSIS AND HAEMOSTASIS
    15. Eichinger, S; Kyrle, PA; Pabinger, I; Lechner, K
      The risk of recurrent venous thromboembolic disease - implications for treatment

      ACUTE PULMONARY EMBOLISM
    16. Rintelen, C; Mannhalter, C; Lechner, K; Eichinger, S; Kyrle, PA; Papagiannopoulos, M; Schneider, B; Pabinger, I
      No evidence for an increased risk of venous thrombosis in patients with factor V Leiden by the homozygous 677 C to T mutation in the methylenetetrahydrofolate-reductase gene

      BLOOD COAGULATION & FIBRINOLYSIS
    17. Meidlinger, P; Knobl, P; Jager, U; Gisslinger, H; Pabinger, I; Weltermann, A; Lechner, K; Geissler, K
      Granulocyte colony-stimulating factor-supported combined immunosuppressivetherapy (antilymphocyte globulin, cyclosporine, and methylprednisolone) inpatients with aplastic anemia: tolerability, efficacy, and changes in the progenitor cell compartment

      ANNALS OF HEMATOLOGY
    18. Pabinger-Fasching, I
      Genetic and acquired risk factors for thromboembolism

      ACTA MEDICA AUSTRIACA
    19. Male, C; Lechner, K; Eichinger, S; Kyrle, PA; Kapiotis, S; Wank, H; Kaider, A; Pabinger, I
      Clinical significance of lupus anticoagulants in children

      JOURNAL OF PEDIATRICS
    20. Winkler, UH; Norris, L; Gaspard, U; van Enk, A; Mishell, D; Voncken, D; Klipping, C; David, J; van den Ende, A; Jespersen, J; Pabinger, I; MacRae, K; Crosignani, P; Skouby, S
      An open label, randomized study to evaluate the effects of seven monophasic oral contraceptive regimens on hemostatic variables - Outline of the protocol

      CONTRACEPTION
    21. Gisslinger, H; Rodeghiero, F; Ruggeri, M; Fard, NHV; Mannhalter, C; Papagiannopoulos, M; Rintelen, C; Lalouschek, W; Knobl, P; Lechner, K; Pabinger, I
      Homocysteine levels in polycythaemia vera and essential thrombocythaemia

      BRITISH JOURNAL OF HAEMATOLOGY
    22. KYRLE PA; MANNHALTER C; BEGUIN S; STUMPFLEN A; HIRSCHL M; WELTERMANN A; STAIN M; BRENNER B; SPEISER W; PABINGER I; LECHNER K; EICHINGER S
      CLINICAL-STUDIES AND THROMBIN GENERATION IN PATIENTS HOMOZYGOUS OR HETEROZYGOUS FOR THE G20210A MUTATION IN THE PROTHROMBIN GENE

      Arteriosclerosis, thrombosis, and vascular biology
    23. MUSTAFA S; MANNHALTER C; RINTELEN C; KYRLE PA; KNOBL P; LECHNER K; PABINGER I
      CLINICAL-FEATURES OF THROMBOPHILIA IN FAMILIES WITH GENE DEFECTS IN PROTEIN-C OR PROTEIN-S COMBINED WITH FACTOR-V-LEIDEN

      Blood coagulation & fibrinolysis
    24. WELTERMANN A; PABINGER I; GEISSLER K; JAGER U; GISSLINGER H; KNOBL P; EICHINGER S; KYRLE PA; VALENT P; SPEISER W; SCHWARZINGER I; MANNHALTER C; LECHNER K
      HYPOFIBRINOGENEMIA IN NON-M3 ACUTE MYELOID-LEUKEMIA - INCIDENCE, CLINICAL AND LABORATORY CHARACTERISTICS AND PROGNOSIS

      Leukemia
    25. EICHINGER S; STUMPFLEN A; HIRSCHL M; BIALONCZYK C; HERKNER K; STAIN M; SCHNEIDER B; PABINGER I; LECHNER K; KYRLE PA
      HYPERHOMOCYSTEINEMIA IS A RISK FACTOR OF RECURRENT VENOUS THROMBOEMBOLISM

      Thrombosis and haemostasis
    26. PANZER S; GSCHWANDTNER ME; HUTTER D; SPITZAUER S; PABINGER I
      SPECIFICITIES OF PLATELET AUTOANTIBODIES IN PATIENTS WITH LUPUS ANTICOAGULANTS IN PRIMARY ANTIPHOSPHOLIPID SYNDROME

      Annals of hematology
    27. KYRLE PA; STUMPFLEN A; HIRSCHL M; BIALONCZYK C; HERKNER K; SPEISER W; WELTERMANN A; KAIDER A; PABINGER I; LECHNER K; EICHINGER S
      LEVELS OF PROTHROMBIN FRAGMENT F1+2 IN PATIENTS WITH HYPERHOMOCYSTEINEMIA AND A HISTORY OF VENOUS THROMBOEMBOLISM

      Thrombosis and haemostasis
    28. GANDRILLE S; BORGEL D; IRELAND H; LANE DA; SIMMONDS R; REITSMA PH; MANNHALTER C; PABINGER I; SAITO H; SUZUKI K; FORMSTONE C; COOPER DN; ESPINOSA Y; SALA N; BERNARDI F; ALACH M
      PROTEIN-S DEFICIENCY - A DATABASE OF MUTATIONS - FOR THE PLASMA COAGULATION INHIBITORS SUBCOMMITTEE OF THE SCIENTIFIC AND STANDARDIZATION COMMITTEE OF THE INTERNATIONAL-SOCIETY-ON-THROMBOSIS-AND-HEMOSTASIS

      Thrombosis and haemostasis
    29. KYRLE PA; EICHINGER S; PABINGER I; STUMPFLEN A; HIRSCHL M; BIALONCZYK C; SCHNEIDER B; MANNHALTER C; MELICHART M; TRAXLER G; WELTERMANN A; SPEISER W; LECHNER K
      PROTHROMBIN FRAGMENT F1+2 IS NOT PREDICTIVE FOR RECURRENT VENOUS THROMBOEMBOLISM

      Thrombosis and haemostasis
    30. EICHINGER S; PABINGER I; STUMPFLEN A; HIRSCHL M; BIALONCZYK C; SCHNEIDER B; MANNHALTER C; MINAR E; LECHNER K; KYRLE PA
      THE RISK OF RECURRENT VENOUS THROMBOEMBOLISM IN PATIENTS WITH AND WITHOUT FACTOR-V-LEIDEN

      Thrombosis and haemostasis
    31. RINTELEN C; PABINGER I; LECHNER K; MANNHALTER C
      IMPACT OF FACTOR-V LEIDEN MUTATION ON DURATION OF ANTICOAGULATION AFTER A SINGLE THROMBOEMBOLIC EVENT

      Thrombosis and haemostasis
    32. GISSLINGER H; RINTELEN C; MUSIL N; KNOBL P; LECHNER K; PABINGER I
      ELEVATED LEVELS OF HOMOCYSTEINE IN PATIENTS WITH POLYCYTHEMIA-VERA AND ESSENTIAL THROMBOCYTHEMIA

      Thrombosis and haemostasis
    33. EICHINGER S; STUMPFLEN A; HIRSCHL M; BIALONCZYK C; PABINGER I; HERKNER K; SCHNEIDER B; LECHNER K; KYRLE PA
      HYPERHOMOCYSTEINEMIA (H-HC) IS A RISK FACTOR OF RECURRENT VENOUS THROMBOEMBOLISM (VTE) IN MALE-PATIENTS

      Thrombosis and haemostasis
    34. SCHUH J; NIESSNER H; PAPAGIANNOPOULOS M; SCHNEIDER B; KNOBL P; PABINGER I
      HYPERHOMOCYSTEINEMIA IS NOT ASSOCIATED WITH POSTOPERATIVE VENOUS THROMBOEMBOLISM IN ORTHOPEDIC-SURGERY

      Thrombosis and haemostasis
    35. KYRLE PA; EICHINGER S; STUMPFLEN A; HIRSCHL M; BIALONCZYK C; HERKNER K; PABINGER I; SPEISER W; SCHNEIDER B; LECHNER K
      HEMOSTATIC SYSTEM ACTIVATION IN PATIENTS WITH HYPERHOMOCYSTEINEMIA (H-HC)

      Thrombosis and haemostasis
    36. RINTELEN C; PABINGER I; LECHNER K; EICHINGER S; KYRLE PA; MANNHALTER C
      NO EVIDENCE FOR AN INCREASE OF THE RISK OF VENOUS THROMBOSIS IN PATIENTS WITH FACTOR-V-LEIDEN BY THE HOMOZYGOUS MUTATION IN THE METHYLENETETRAHYDROFOLATE REDUCTASE GENE

      Thrombosis and haemostasis
    37. RINTELEN C; SCHARRER I; KLINKE S; MANNHALTER C; EICHINGER S; KYRLE PA; LECHNER K; PABINGER I
      HIGH PREVALENCE OF STILLBIRTHS IN WOMEN HOMOZYGOUS FOR FACTOR-V-LEIDEN MUTATION

      Thrombosis and haemostasis
    38. FODINGER M; MANNHALTER C; WOLFL G; PABINGER I; MULLER E; SCHMID R; HORL WH; SUNDERPLASSMANN G
      MUTATION-(677-C-TO-T) IN THE METHYLENETETRAHYDROFOLATE REDUCTASE GENEAGGRAVATES HYPERHOMOCYSTEINEMIA IN HEMODIALYSIS-PATIENTS

      Kidney international
    39. RUZICKA K; KAPIOTIS S; QUEHENBERGER P; HANDLER S; HORNYKEWYCZ S; MICHITSCH A; HUBER K; CLEMENS D; SUSAN M; PABINGER I; EICHINGER S; JILMA B; SPEISER W
      EVALUATION OF BEDSIDE PROTHROMBIN TIME AND ACTIVATED PARTIAL THROMBOPLASTIN TIME MEASUREMENT BY COAGULATION ANALYZER COAGUCHEK PLUS(R) IN VARIOUS CLINICAL SETTINGS

      Thrombosis research
    40. STEINDL P; FERENCI P; DIENES HP; GRIMM G; PABINGER I; MADL C; MAIERDOBERSBERGER T; HERNETH A; DRAGOSICS B; MERYN S; KNOFLACH P; GRANDITSCH G; GANGL A
      WILSONS-DISEASE IN PATIENTS PRESENTING WITH LIVER-DISEASE - A DIAGNOSTIC CHALLENGE

      Gastroenterology
    41. MUSTAFA S; PABINGER I; VARADI K; HALBMAYER WM; LECHNER K; SCHWARZ HP; FISCHER M; MANNHALTER C
      A HITHERTO UNKNOWN SPLICE-SITE DEFECT IN THE PROTEIN-S GENE (PROS1) -THE MUTATION RESULTS IN ALLELIC EXCLUSION AND CAUSES TYPE-I AND TYPE-III PROTEIN-S DEFICIENCY

      British Journal of Haematology
    42. PANZER S; PABINGER I; GSCHWANDTNER ME; MAYR WR; HUTTER D
      LUPUS ANTICOAGULANTS - STRONG ASSOCIATION WITH THE MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-II AND PLATELET ANTIBODIES

      British Journal of Haematology
    43. MUSTAFA S; PABINGER I; MANNHALTER C
      A FREQUENT MUTATION IN THE PROTEIN-S GENE RESULTS IN CRYPTIC SPLICING

      British Journal of Haematology
    44. GEISSLER K; KOLLER E; HUBMANN E; NIEDERWIESER D; HINTERBERGER W; GEISSLER D; KYRLE P; KNOBL P; PABINGER I; THALHAMMER R; SCHWARZINGER I; MANNHALTER C; JAEGER U; HEINZ R; LINKESCH W; LECHNER K
      GRANULOCYTE-COLONY-STIMULATING FACTOR AS AN ADJUNCT TO INDUCTION CHEMOTHERAPY FOR ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA - A RANDOMIZED PHASE-III STUDY

      Blood
    45. ZIVELIN A; GRIFFIN JH; XU X; PABINGER I; SAMAMA M; CONARD J; BRENNER B; ELDOR A; SELIGSOHN U
      A SINGLE GENETIC-ORIGIN FOR A COMMON CAUCASIAN RISK FACTOR FOR VENOUSTHROMBOSIS

      Blood
    46. PABINGER I; SCHNEIDER B
      THROMBOTIC RISK IN HEREDITARY ANTITHROMBIN-III, PROTEIN-C, OR PROTEIN-S DEFICIENCY - A COOPERATIVE, RETROSPECTIVE STUDY

      Arteriosclerosis, thrombosis, and vascular biology
    47. GSCHWANDTNER ME; EICHINGER S; HUTTER D; KORNINGER L; LECHNER K; PANZER S; PABINGER I
      LUPUS ANTICOAGULANT AND THROMBOEMBOLISM - EVALUATION OF FIBRINOGEN, NATURAL INHIBITORS AND MOLECULAR MARKERS OF THROMBOSIS

      Blood coagulation & fibrinolysis
    48. HUHMANN IM; WATZKE HH; GEISSLER K; GISSLINGER H; JAGER U; KNOBL P; PABINGER I; KORNINGER L; MANNHALTER C; MITTERBAUER G; SCHWARZINGER I; KALHS P; HAAS OA; LECHNER K
      FLAG (FLUDARABINE, CYTOSINE-ARABINOSIDE, G-CSF) FOR REFRACTORY AND RELAPSED ACUTE MYELOID-LEUKEMIA

      Annals of hematology
    49. MITTERBAUER M; FRITZERSZEKERES M; MITTERBAUER G; SIMONITSCH I; KNOBL P; RINTELEN C; SCHWARZINGER I; HAAS OA; SILBERBAUER K; FREY K; BIBUS B; PABINGER I; RADASZKIEWICZ T; LECHNER K; JAEGER U
      SPONTANEOUS REMISSION OF ACUTE MYELOID-LEUKEMIA AFTER INFECTION AND BLOOD-TRANSFUSION ASSOCIATED WITH HYPERGAMMAGLOBULINEMIA

      Annals of hematology
    50. THALHAMMER F; GEISSLER K; JAGER U; KYRLE PA; PABINGER I; MITTERBAUER M; GISSLINGER H; KNOBL P; LACZIKA K; SCHNEIDER B; HAAS OA; LECHNER K
      DURATION OF 2ND COMPLETE REMISSION IN PATIENTS WITH ACUTE MYELOID-LEUKEMIA TREATED WITH CHEMOTHERAPY - A RETROSPECTIVE SINGLE-CENTER STUDY

      Annals of hematology
    51. FODINGER M; MANNHALTER C; PABINGER I; KOIZAR D; RINTELEN C; HORL WH; SUNDERPLASSMANN G
      RESISTANCE TO ACTIVATED PROTEIN-C (APC) - MUTATION AT ARG(506) OF COAGULATION-FACTOR-V AND VASCULAR ACCESS THROMBOSIS IN HEMODIALYSIS-PATIENTS

      Nephrology, dialysis, transplantation
    52. MUSTAFA S; PABINGER I; MANNHALTER C
      2 NEW FREQUENT DIMORPHISMS IN THE PROTEIN-S (PROS1) GENE

      Thrombosis and haemostasis
    53. LANG IM; KLEPETKO W; PABINGER I
      NO INCREASED PREVALENCE OF THE FACTOR-V LEIDEN MUTATION IN CHRONIC MAJOR VESSEL THROMBOEMBOLIC PULMONARY-HYPERTENSION (CTEPH)

      Thrombosis and haemostasis
    54. VARADI K; ROSING J; TANS G; PABINGER I; KEIL B; SCHWARZ HP
      FACTOR-V ENHANCES THE COFACTOR FUNCTION OF PROTEIN-S IN THE APC-MEDIATED INACTIVATION OF FACTOR-VIII - INFLUENCE OF THE FACTOR V-R506Q MUTATION

      Thrombosis and haemostasis
    55. RINTELEN C; PABINGER I; KNOBL P; LECHNER K; MANNHALTER C
      PROBABILITY OF RECURRENCE OF THROMBOSIS IN PATIENTS WITH AND WITHOUT FACTOR-V LEIDEN

      Thrombosis and haemostasis
    56. RINTELEN C; MANNHALTER C; PABINGER I; SCHARRER I; KLINKE S
      ORAL ANTICOAGULANTS AND FETAL LOSS

      Lancet
    57. PRESTON FE; ROSENDAAL FR; WALKER ID; BRIET E; BERNTORP E; CONARD J; FONTCUBERTA J; MAKRIS M; MARIANI G; NOTEBOOM W; PABINGER I; LEGNANI C; SCHARRER I; SCHULMAN S; VANDERMEER FJM
      INCREASED FETAL LOSS IN WOMEN WITH HERITABLE THROMBOPHILIA

      Lancet
    58. MELICHART M; KYRLE PA; EICHINGER S; RINTELEN C; MANNHALTER C; PABINGER I
      THROMBOTIC TENDENCY IN 75 SYMPTOMATIC, UNRELATED PATIENTS WITH APC RESISTANCE

      Wiener Klinische Wochenschrift
    59. RINTELEN C; MANNHALTER C; IRELAND H; LANE DA; KNOBL P; LECHNER K; PABINGER I
      ORAL-CONTRACEPTIVES ENHANCE THE RISK OF CLINICAL MANIFESTATION OF VENOUS THROMBOSIS AT A YOUNG AGE IN FEMALES HOMOZYGOUS FOR FACTOR-V LEIDEN

      British Journal of Haematology
    60. MANNHALTER C; MUSTAFA S; PABINGER I
      IDENTIFICATION OF 2 FREQUENT DIMORPHISMS IN THE PROTEIN-S GENE

      Blood
    61. RINTELEN C; PABINGER I; LECHNER K; EICHINGER S; KYRLE PA; MANNHALTER C
      HOMOZYGOUS C-]T MUTATION IN THE METHYLENE TETRAHYDROFOLATE REDUCTASE (MTHFR) GENE DOES NDT INCREASE THE RISK FOR VENOUS THROMBOSIS IN PATIENTS WITH THE FACTOR-V LEIDEN MUTATION

      Blood
    62. ZIVELIN A; GRIFFIN JH; XU X; PABINGER I; SAMAMA M; CONARD J; BRENNER B; ELDOR A; SELIGSOHN U
      A SINGLE GENETIC-ORIGIN FOR THE COMMON CAUCASIAN FACTOR-V MUTATION PREDISPOSING TO THROMBOSIS

      Blood
    63. GSCHWANDTNER ME; LECHNER K; PABINGER I
      ERRONEOUSLY LOW APC RATIO IN PATIENTS WITH LUPUS ANTICOAGULANT

      Annals of hematology
    64. KNOBL P; DERFLER K; KORNINGER L; KAPIOTIS S; JAGER U; MAIERDOBERSBERGER T; HORL W; LECHNER K; PABINGER I
      ELIMINATION OF ACQUIRED FACTOR-VIII ANTIBODIES BY EXTRACORPOREAL ANTIBODY-BASED IMMUNOADSORPTION (IG-THERASORB(R))

      Thrombosis and haemostasis
    65. EICHINGER S; PABINGER I; SCHNEIDER B; STUMPFLEN A; HIRSCHL C; BIALONCZYK C; MELICHART M; RINTELEN C; LECHNER K; KYRTE PA
      THE RISK OF RECURRENCE OF VENOUS THROMBOEMBOLISM (VTE) - THE PREDICTIVE VALUE OF DETERMINATION OF ACTIVATED PROTEIN-C (APC) - RESISTANCE AND OF MONITORING MOLECULAR MARKERS OF THROMBOSIS

      Thrombosis and haemostasis
    66. RINTELEN C; BAYSTON TA; IRELAND H; LANE DA; MANNHALTER C; PABINGER I
      CLINICAL-FEATURE IN PATIENTS WITH HOMOZYGOUS AND HETEROZYGOUS FACTOR-V LEIDEN MUTATION (APC-RESISTANCE) AND A HISTORY OF VENOUS THROMBOEMBOLISM

      Thrombosis and haemostasis
    67. VARADI K; KEIL B; ROSING J; TANS G; PABINGER I; SCHWARZ HP
      THE COMBINED EFFECT OF PURIFIED FACTOR-V AND PROTEIN-S ON THE APC-MEDIATED INACTIVATION OF FACTOR VIIIA

      Thrombosis and haemostasis
    68. IRELAND H; BAYSTON TA; CHOWDHURY V; THEIN SL; CONARD J; PABINGER I; LANE DA
      FACTOR-V LEIDEN AS AN INDEPENDENT RISK FACTOR FOR THROMBOSIS IN ANTITHROMBIN DEFICIENCY TYPE-II - HEPARIN-BINDING SITE

      Thrombosis and haemostasis
    69. PABINGER I; MUSTAFA S; RINTELEN C; KYRLE PA; LECHNER K; MANNHALTER C
      FACTOR-V (FV) LEIDEN MUTATION (APC-RESISTANCE) INCREASES THE RISK FORVENOUS THROMBOEMBOLISM IN PATIENTS WITH A GENE DEFECT OF THE PROTEIN-C (PC) OR PROTEIN-S (PS) GENE

      Thrombosis and haemostasis
    70. RINTELEN C; KNOBL P; OVISSI L; PABINGER I; MANNHALTER C
      FACTOR-V LEIDEN IS NOT A PREDICTIVE PARAMETER FOR RECURRENT THROMBOSIS IN PATIENTS (PTS) WITH A HISTORY OF VENOUS THROMBOSIS (VT)

      Thrombosis and haemostasis
    71. KNOBL P; DERFLER K; KORNINGER L; KAPIOTIS S; JAGER U; MAIENDOBERSBERGER T; TRIBL B; SPEISER W; DRUML W; PABINGER I; LECHNER K
      ELIMINATION OF ACQUIRED INHIBITORS TO FACTOR-VIII AND FACTOR-V WITH IMMUNOSPECIFIC IMMUNOGLOBULIN APHERESIS

      Thrombosis and haemostasis
    72. HERNANDEZ A; UHRBERG M; ENCZMANN J; WITT J; REITSMA P; SCHARRER I; PABINGER I; WERNET P
      RAPID SCREENING OF POINT MUTATIONS IN THE PROTEIN-C GENE BY TEMPERATURE-GRADIENT GEL-ELECTROPHORESIS IN A GROUP OF 44 PATIENTS AND 15 FAMILIES WITH PROTEIN-C DEFICIENCY - DETECTION OF A NOVEL MUTATION IN THE EXON-IX OF THE PROTEIN-C GENE

      Experimental hematology
    73. NICOLAES GAF; TANS G; THOMASSEN MCLGD; HEMKER HC; PABINGER I; VARADI K; SCHWARZ HP; ROSING J
      PEPTIDE-BOND CLEAVAGES AND LOSS OF FUNCTIONAL-ACTIVITY DURING INACTIVATION OF FACTOR VA AND FACTOR VA(R506Q) BY ACTIVATED PROTEIN-C

      The Journal of biological chemistry
    74. CHOWDHURY V; MILLE B; OLDS RJ; LANE DA; WATTON J; BARROWCLIFFE TW; PABINGER I; WOODCOCK BE; THEIN SL
      ANTITHROMBINS SOUTHPORT (LEU 99 TO VAL) AND VIENNA (GIN 118 TO PRO) -2 NOVEL ANTITHROMBIN VARIANTS WITH ABNORMAL HEPARIN-BINDING

      British Journal of Haematology
    75. MUSTAFA S; PABINGER I; MANNHALTER C
      PROTEIN-S DEFICIENCY TYPE-I - IDENTIFICATION OF POINT MUTATIONS IN 9 OF 10 FAMILIES

      Blood
    76. RINTELEN C; PABINGER I; KNOBL P; LECHNER K; MANNHALTER C
      ORAL-CONTRACEPTIVES ARE THE MOST IMPORTANT PRECIPITATING FACTOR FOR VENOUS THROMBOSIS IN YOUNG FEMALES HOMOZYGOUS FOR ARG-506 GLN MUTATION IN THE FACTOR-V GENE

      Blood
    77. EICHINGER S; PABINGER I; STUMPFLEN A; HIRSCHL M; BIALONCZYK C; FORBERG E; SCHNEIDER B; RINTELEN C; LECHNER K; KYRLE PA
      THE RISK OF RECURRENT VENOUS THROMBOEMBOLISM (VTE) AFTER DISCONTINUATION OF ORAL ANTICOAGULANTS (OAC) IN PATIENTS WITHOUT AND WITH FACTOR-V(FV) LEIDEN AND THE PREDICTIVE VALUE OF A MOLECULAR MARKER OF THROMBOSIS

      Blood
    78. SPERR WR; AGIS H; PIRIBAUER M; SEMPER H; SCHWARZINGER I; PABINGER I; WATZKE H; GEISSLER K; VALENT P; LECHNER K
      CYCLIC CHANGES OF GRANULOCYTE COUNTS DURING AND AFTER CONSOLIDATION TREATMENT WITH HIGH-DOSE ARA-C (HIDAC)

      Blood
    79. GISSLINGER H; RINTELEN C; MANNHALTER C; PABINGER I; GEISSLER K; KNOBL P; EICHINGER S; LECHNER K
      FACTOR-V LEIDEN MUTATION IS NOT A MAJOR CAUSE OF THROMBOTIC TENDENCY IN ESSENTIAL THROMBOCYTHEMIA (ET) AND POLYCYTHEMIA-VERA (PV)

      Blood
    80. OLDS RJ; LANE DA; CHOWDHURY V; SAS G; PABINGER I; AUBERGER K; THEIN SL
      (ATT) TRINUCLEOTIDE REPEATS IN THE ANTITHROMBIN GENE AND THEIR USE INDETERMINING THE ORIGIN OF REPEATED MUTATIONS

      Human mutation
    81. GAIGER A; NEUMEISTER A; HEINZL H; PABINGER I; PANZER S
      HLA CLASS-I AND CLASS-II ANTIGENS IN CHRONIC IDIOPATHIC AUTOIMMUNE THROMBOCYTOPENIA

      Annals of hematology
    82. CHOWDHURY V; LANE DA; MILLE B; AUBERGER K; GANDENBERGERBACHEM S; PABINGER I; OLDS RJ; THEIN SL
      HOMOZYGOUS ANTITHROMBIN DEFICIENCY - REPORT OF 2 NEW CASES (99-LEU TOPHE) ASSOCIATED WITH ARTERIAL AND VENOUS THROMBOSIS

      Thrombosis and haemostasis
    83. BRIET E; ROSENDAAL FR; KREUZ W; RASI V; PEERLINCK K; VERMYLEN J; LJUNG R; ROCINO A; ADDIEGO J; LORENZO JI; PABINGER I
      HIGH-TITER INHIBITORS IN SEVERE HEMOPHILIA-A - A METAANALYSIS BASED ON 8 LONG-TERM FOLLOW-UP-STUDIES CONCERNING INHIBITORS ASSOCIATED WITH CRUDE OR INTERMEDIATE PURITY FACTOR-VIII PRODUCTS

      Thrombosis and haemostasis
    84. PABINGER I; SCHNEIDER B; SCHARRER I; HACHWUNDERLE V; LECHNER K; EICHINGER S; KYRLE PA; VINAZZER H; LAMMLE B; DEMARMELSBIASIUTTI F; TILSNER V; MARX G; SEIFRIED E; GABELMANN A; ASPOCK G; FISCHER M; HALBMAYER WM
      THROMBOTIC RISK OF WOMEN WITH HEREDITARY ANTITHROMBIN-III-DEFICIENCY,PROTEIN C-DEFICIENCY AND PROTEIN S-DEFICIENCY TAKING ORAL-CONTRACEPTIVE MEDICATION

      Thrombosis and haemostasis
    85. PABINGER I; KYRLE PA; HEISTINGER M; EICHINGER S; WITTMANN E; LECHNER K
      THE RISK OF THROMBOEMBOLISM IN ASYMPTOMATIC PATIENTS WITH PROTEIN-C AND PROTEIN-S DEFICIENCY - A PROSPECTIVE COHORT STUDY

      Thrombosis and haemostasis
    86. GEISSLER K; KOLLER E; HINTERBERGER W; NIEDERWIESER D; KNOBL P; PABINGER I; WERNER D; SCHERRER R; SCHWARZINGER I; FRIEDL J; JAEGER U; LECHNER K
      CONCOMITANT ADMINISTRATION OF GRANULOCYTE-COLONY-STIMULATING FACTOR (G-CSF) AND INDUCTION CHEMOTHERAPY OF ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL) - 1ST RESULTS OF A MULTICENTER, OPEN-LABEL, PHASE-III STUDY INRANDOMIZED PARALLEL GROUPS

      Blood
    87. JAEGER U; KAPIOTIS S; PABINGER I; PUCHHAMMER E; KYRLE PA; LECHNER K
      TRANSIENT LUPUS ANTICOAGULANT ASSOCIATED WITH HYPOPROTHROMBINEMIA ANDFACTOR-XII DEFICIENCY FOLLOWING ADENOVIRUS INFECTION

      Annals of hematology
    88. CHOWDHURY V; OLDS RJ; LANE DA; PABINGER I; MACHIN SJ; RYAN K; BAUER KA; BHAVNANI M; ABILDGAARD U; FINAZZI G; CONARD J; HORELLOU MH; CASTAMAN G; MANNUCCI PM; THEIN SL
      IDENTIFICATION OF 9 NOVEL MUTATIONS IN TYPE-I ANTITHROMBIN DEFICIENCYBY HETERODUPLEX SCREENING

      Thrombosis and haemostasis
    89. EICHINGER S; NIESZPAURLOS M; SCHNEIDER B; WOLZT M; PABINGER I; EICHLER HG; LECHNER K; KYRLE PA
      EFFECTS OF LOW-MOLECULAR-WEIGHT HEPARIN (LMWH) AND UNFRACTIONATED HEPARIN (UFH) ON COAGULATION AND PLATELET ACTIVATION AT THE SITE OF PLUG FORMATION

      Thrombosis and haemostasis
    90. OLDS RJ; LANE DA; CHOWDHURY V; SAS G; PABINGER I; THEIN SL
      ANTITHROMBIN VARIANTS WITH REDUCED HEPARIN-BINDING AFFINITY RESULTINGFROM THE SUBSTITUTION L99F - EVIDENCE FOR A FOUNDER EFFECT

      Thrombosis and haemostasis
    91. PABINGER I; SCHNEIDER B
      THROMBOTIC RISK OF WOMEN WITH HEREDITARY ANTITHROMBIN-III-DEFICIENCY PROTEIN-C-DEFICIENCY AND PROTEIN-S-DEFICIENCY TAKING ORAL-CONTRACEPTIVE MEDICATION

      Thrombosis and haemostasis
    92. PABINGER I; KYRLE P; LACK W; FUNOVICS J
      PERIOPERATIVE BLEEDING PROPHYLAXIS USING PURIFIED FACTOR-IX CONCENTRATE DURING SURGERY ON 2 PATIENTS WITH HEMOPHILIA-B

      Thrombosis and haemostasis
    93. HAUSER I; GISSLINGER H; LOCKER G; ELBL W; KYRLE PA; PABINGER I; LECHNER K
      POSTPARTUM FACTOR-VIII INHIBITORS - REPORT OF 2 CASES WITH SPECIAL REFERENCE TO THE EFFICACY OF VARIOUS TREATMENTS

      Wiener Klinische Wochenschrift
    94. CHOWDHURY V; OLDS RJ; LANE DA; CONARD J; PABINGER I; RYAN K; BAUER KA; BHAVNANI M; ABILDGAARD U; FINAZZI G; CASTAMAN G; MANNUCCI PM; THEIN SL
      IDENTIFICATION OF 9 NOVEL MUTATIONS IN TYPE-I ANTITHROMBIN DEFICIENCYBY HETERODUPLEX SCREENING

      British Journal of Haematology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 28/10/20 alle ore 04:37:59